AU2001251502A1 - Nuclear magnetic resonance methods for identifying sites in papillomavirus e2 protein - Google Patents

Nuclear magnetic resonance methods for identifying sites in papillomavirus e2 protein

Info

Publication number
AU2001251502A1
AU2001251502A1 AU2001251502A AU5150201A AU2001251502A1 AU 2001251502 A1 AU2001251502 A1 AU 2001251502A1 AU 2001251502 A AU2001251502 A AU 2001251502A AU 5150201 A AU5150201 A AU 5150201A AU 2001251502 A1 AU2001251502 A1 AU 2001251502A1
Authority
AU
Australia
Prior art keywords
papillomavirus
protein
magnetic resonance
nuclear magnetic
resonance methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001251502A
Inventor
Brian J. Stockman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of AU2001251502A1 publication Critical patent/AU2001251502A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
AU2001251502A 2000-04-17 2001-04-10 Nuclear magnetic resonance methods for identifying sites in papillomavirus e2 protein Abandoned AU2001251502A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US19745900P 2000-04-17 2000-04-17
US60197459 2000-04-17
US21105500P 2000-06-13 2000-06-13
US60211055 2000-06-13
US26844401P 2001-02-13 2001-02-13
US60268444 2001-02-13
PCT/US2001/011621 WO2001079852A2 (en) 2000-04-17 2001-04-10 Nmr-methods for indentifying sites in papillomavirus e2 protein
US09829872 2001-04-10
US09/829,872 US20010051333A1 (en) 2000-04-17 2001-04-10 Nuclear magnetic resonance methods for identifying sites in papillomavirus E2 protein

Publications (1)

Publication Number Publication Date
AU2001251502A1 true AU2001251502A1 (en) 2001-10-30

Family

ID=27498160

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001251502A Abandoned AU2001251502A1 (en) 2000-04-17 2001-04-10 Nuclear magnetic resonance methods for identifying sites in papillomavirus e2 protein

Country Status (3)

Country Link
US (1) US20010051333A1 (en)
AU (1) AU2001251502A1 (en)
WO (1) WO2001079852A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6677160B1 (en) * 1999-09-29 2004-01-13 Pharmacia & Upjohn Company Methods for creating a compound library and identifying lead chemical templates and ligands for target molecules
US20040185506A1 (en) * 2003-03-21 2004-09-23 Heavner George A. Epitope mapping using nuclear magnetic resonance

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60107554A (en) * 1983-11-16 1985-06-13 Ube Ind Ltd Method and device for determining chemical structure of unknown material
US5270163A (en) * 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
EP0593618B1 (en) * 1991-06-27 1998-04-22 Genelabs Technologies, Inc. Screening assay for the detection of dna-binding molecules
WO1995029690A1 (en) * 1994-04-29 1995-11-09 The Trustees Of The University Of Pennsylvania Biologically active peptides and methods of identifying the same
US5668734A (en) * 1995-04-10 1997-09-16 The Uab Research Foundation Method for analyzing 2D transferred noesy spectra of molecules undergoing multistate conformational exchange
US5698401A (en) * 1995-11-14 1997-12-16 Abbott Laboratories Use of nuclear magnetic resonance to identify ligands to target biomolecules
US5989827A (en) * 1995-11-14 1999-11-23 Abbott Laboratories Use of nuclear magnetic resonance to design ligands to target biomolecules
US5891643A (en) * 1995-11-14 1999-04-06 Abbott Laboratories Use of nuclear magnetic resonance to design ligands to target biomolecules
GB9610811D0 (en) * 1996-05-23 1996-07-31 Pharmacia Spa Combinatorial solid phase synthesis of a library of indole derivatives
DE19649359C1 (en) * 1996-11-28 1998-02-12 Thomas Prof Dr Peters Detecting biologically active substances in substance libraries
US6043024A (en) * 1997-04-18 2000-03-28 Abbott Laboratories Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules
US6677160B1 (en) * 1999-09-29 2004-01-13 Pharmacia & Upjohn Company Methods for creating a compound library and identifying lead chemical templates and ligands for target molecules

Also Published As

Publication number Publication date
WO2001079852A2 (en) 2001-10-25
WO2001079852A3 (en) 2002-06-13
US20010051333A1 (en) 2001-12-13

Similar Documents

Publication Publication Date Title
AU2002210847A1 (en) Magnetic resonance imaging device
AU2001253164A1 (en) Usage based strength between related information in an information retrieval system
AU2001253644A1 (en) Method and system for collecting related queries
EP1212452A4 (en) Methods for encoding and sorting in vitro translated proteins
AP2002002658A0 (en) Hepatitis b core antigen fusion proteins
IL149029A0 (en) High mannose proteins and methods for producing the same
AU2001259631A1 (en) Methods and vectors for generating antibodies in avian species and uses therefor
AU2001262178A1 (en) Grid-waveguide structure for reinforcing an excitation field and use thereof
AU7354298A (en) Incubator arrangement for use in magnetic resonance imaging
AU2001286536A1 (en) System and method for automated credit matching
GB2369438B (en) Nuclear magnetic resonance apparatus
AU6420201A (en) System for workflow analysis and response
AU2001265266A1 (en) Microcolumn for use in sample extraction
AU2002221740A1 (en) Method for analyzing proteins
AU2001275173A1 (en) Peptides for use in culture media
AU2002219915A1 (en) Methods for optimizing magnetic resonance imaging systems
AU2001251502A1 (en) Nuclear magnetic resonance methods for identifying sites in papillomavirus e2 protein
AU2003295288A1 (en) Magnetic resonance imaging method and compounds for use in the method
AU2001293300A1 (en) Automated core biopsy instrument and methods
AU2002243285A1 (en) Auxiliary metering apparatus and methods
AU2002246912A1 (en) Receptor-binding compounds and methods for identifying them
ZA200207301B (en) Magnetic resonance specimen analysis apparatus.
AU2001253041A1 (en) Dendrimer composition for magnetic resonance analysis
AU2001261697A1 (en) Methods for identifying novel therapeutics and diagnostics in the p53 pathway
AU2001259764A1 (en) Method for using hard magnetic carriers in an electrographic process